Drug:
Reaction: TOXICITY TO VARIOUS AGENTS
20250101 - 20251231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 25073481 |
US |
||
Toxic encephalopathy, Metabolic acidosis, Lactic acidosis, Toxicity to various agents, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, GABAPENTIN, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, |
||||
| 402 | 25073603 |
IN |
||
Shock, Blood potassium abnormal, Blood calcium abnormal, Blood glucose increased, Toxicity to various agents, Intentional overdose, |
||||
AMLODIPINE, GLIMEPIRIDE, |
||||
| 403 | 25073774 |
US |
61 | 1 |
Epstein-Barr virus associated lymphoma, Cutaneous B-cell lymphoma, Marginal zone lymphoma, Lymphoma transformation, Plasmablastic lymphoma, Upper gastrointestinal haemorrhage, Gastric ulcer haemorrhage, Metastases to lymph nodes, Anaemia macrocytic, Clonal haematopoiesis, Toxicity to various agents, |
||||
METHOTREXATE, METHOTREXATE SODIUM, LEFLUNOMIDE, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, METHYLPREDNISOLONE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, BORTEZOMIB FOR INJECTION, BORTEZOMIB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, SECUKINUMAB, SULFASALAZINE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ETOPOSIDE PHOSPHATE, ETOPOSIDE PHOSPHATE, ETOPOSIDE PHOSPHATE, ETOPOSIDE PHOSPHATE, ETOPOSIDE PHOSPHATE, ETOPOSIDE PHOSPHATE, ETOPOSIDE PHOSPHATE, ETOPOSIDE PHOSPHATE, ETOPOSIDE PHOSPHATE, ETOPOSIDE PHOSPHATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, |
||||
| 404 | 25074141 |
US |
58 | 2 |
Encephalopathy, Lactic acidosis, Hypoglycaemia, Toxicity to various agents, Potentiating drug interaction, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 405 | 25074529 |
DE |
17 | 1 |
Completed suicide, Intentional overdose, Toxicity to various agents, Product use in unapproved indication, |
||||
DICLOFENAC, DICLOFENAC SODIUM, RANITIDINE, |
||||
| 406 | 25074551 |
US |
8 | 1 |
Toxicity to various agents, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, PACLITAXEL, |
||||
| 407 | 25074595 |
US |
61 | 1 |
Malignant neoplasm progression, Drug ineffective, Drug intolerance, Toxicity to various agents, Product use in unapproved indication, |
||||
BENDAMUSTINE HCL, BENDAMUSTINE HCL, DOXORUBICIN, DOXORUBICIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, BORTEZOMIB FOR INJECTION, BORTEZOMIB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, ETOPOSIDE PHOSPHATE, ETOPOSIDE PHOSPHATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, OBINUTUZUMAB, OBINUTUZUMAB, |
||||
| 408 | 25074625 |
FR |
25 | 2 |
Toxicity to various agents, Coma, |
||||
VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, DIAZEPAM, |
||||
| 409 | 25074909 |
FR |
18 | 2 |
Acute hepatic failure, Toxicity to various agents, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 410 | 25074964 |
SE |
19 | 2 |
Intentional overdose, Depressed level of consciousness, Toxicity to various agents, Intentional self-injury, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 411 | 25075521 |
SE |
43 | 2 |
Suicide attempt, Hypoglycaemia, Intentional overdose, Hypokalaemia, Hyponatraemia, Toxicity to various agents, |
||||
| 412 | 25076116 |
IT |
19 | 2 |
Toxicity to various agents, |
||||
VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, LITHIUM CARBONATE, CARBAMAZEPINE, |
||||
| 413 | 25076293 |
US |
16 | 1 |
Renal impairment, Abdominal discomfort, Tremor, Drug interaction, Toxicity to various agents, Oliguria, Glycosuria, Nausea, Vomiting, Dizziness, Chills, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, NIRMATRELVIR AND RITONAVIR, LISINOPRIL AND HYDROCHLOROTHIAZIDE, LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS, |
||||
| 414 | 25076324 |
US |
||
Toxicity to various agents, Adverse drug reaction, |
||||
DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT), |
||||
| 415 | 25076440 |
FR |
56 | 2 |
Pancytopenia, Toxicity to various agents, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 416 | 25076443 |
PL |
14 | 2 |
International normalised ratio increased, Electrolyte imbalance, Vomiting, Dizziness, Toxicity to various agents, Overdose, Drug abuse, |
||||
SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 417 | 25076453 |
GB |
2 | |
Toxicity to various agents, |
||||
ABEMACICLIB, ABEMACICLIB, |
||||
| 418 | 25076743 |
PL |
64 | |
Hypoglycaemic encephalopathy, Toxicity to various agents, |
||||
GLIMEPIRIDE, |
||||
| 419 | 25066010 |
CA |
55 | 2 |
Toxicity to various agents, |
||||
CYCLOBENZAPRINE, NALOXONE HYDROCHLORIDE NASAL, NALOXONE HYDROCHLORIDE, METHADONE, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, CAFFEINE, |
||||
| 420 | 25066275 |
US |
80 | 2 |
Seizure, Drug interaction, Toxicity to various agents, |
||||
RANOLAZINE, EXTENDED-RELEASE, RANOLAZINE, EXTENDED-RELEASE, INSULIN DEGLUDEC, FAMOTIDINE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, LOSARTAN, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, VIBEGRON, INSULIN ASPART, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, MAGNESIUM OXIDE, DAPAGLIFLOZIN, LINACLOTIDE, NIFEDIPINE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, |
||||
| 421 | 25066331 |
US |
16 | 1 |
Drug interaction, Toxicity to various agents, Drug effective for unapproved indication, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, NIRMATRELVIR AND RITONAVIR, |
||||
| 422 | 25066722 |
US |
2 | |
Toxicity to various agents, Seizure, |
||||
RANOLAZINE, EXTENDED-RELEASE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, LOSARTAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DAPAGLIFLOZIN, INSULIN ASPART, INSULIN DEGLUDEC, LEVOTHYROXINE SODIUM, VIBEGRON, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, LINACLOTIDE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, POLYETHYLENE GLYCOL, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, FAMOTIDINE, MAGNESIUM OXIDE, ERGOCALCIFEROL, |
||||
| 423 | 25066983 |
CN |
32 | 2 |
Toxicity to various agents, Intentional overdose, Cardiogenic shock, Acute kidney injury, |
||||
AMLODIPINE BESYLATE, |
||||
| 424 | 25067032 |
FR |
76 | 1 |
Leukopenia, Neutropenia, Fatigue, Cough, Toxicity to various agents, |
||||
ENFORTUMAB VEDOTIN, PEMBROLIZUMAB, |
||||
| 425 | 25067190 |
CN |
32 | 2 |
Vasoplegia syndrome, Acute left ventricular failure, Left ventricular dysfunction, Pulmonary oedema, Acute kidney injury, Shock, Circulatory collapse, Cardiogenic shock, Tachypnoea, Lethargy, Myocardial depression, Lactic acidosis, Hypotension, Sinus tachycardia, Somnolence, Vomiting, Toxicity to various agents, Intentional overdose, Hypocalcaemia, |
||||
AMLODIPINE BESYLATE, |
||||
| 426 | 25067239 |
32 | 2 | |
Cardiogenic shock, Toxicity to various agents, Distributive shock, Intentional overdose, |
||||
AMLODIPINE, |
||||
| 427 | 25067341 |
16 | 1 | |
Toxicity to various agents, Nausea, Vomiting, Dizziness, Chills, Tremor, Glycosuria, Drug interaction, Oliguria, Off label use, Blood creatinine increased, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 428 | 25067898 |
US |
45 | 2 |
Completed suicide, Toxicity to various agents, |
||||
RISPERIDONE, HALOPERIDOL, HALOPERIDOL LACTATE, IRON, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, HYDROXYZINE, GABAPENTIN, |
||||
| 429 | 25068006 |
US |
41 | 1 |
Toxicity to various agents, |
||||
FENTANYL, AMPHETAMINE, |
||||
| 430 | 25068014 |
FR |
15 | 2 |
Toxicity to various agents, Poisoning deliberate, |
||||
ALPRAZOLAM, |
||||
| 431 | 25068854 |
IT |
19 | 2 |
Toxicity to various agents, |
||||
CARBAMAZEPINE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, LITHIUM CARBONATE, |
||||
| 432 | 25069208 |
64 | 2 | |
Dizziness, Nausea, Product adhesion issue, Malaise, Asthenia, Circulatory collapse, Tremor, Dysstasia, Gait inability, Palpitations, Mydriasis, Vision blurred, Toxicity to various agents, Product use issue, |
||||
SCOPOLAMINE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 433 | 25069421 |
US |
81 | 1 |
BRASH syndrome, Toxicity to various agents, |
||||
DIGOXIN, APIXABAN, |
||||
| 434 | 25069441 |
US |
74 | 1 |
BRASH syndrome, Toxicity to various agents, |
||||
DIGOXIN, CARVEDILOL, FUROSEMIDE, SPIRONOLACTONE, VALSARTAN, |
||||
| 435 | 25069611 |
US |
57 | 1 |
Toxicity to various agents, Completed suicide, |
||||
RISPERIDONE, AMLODIPINE, METOPROLOL TARTRATE, METOPROLOL, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, HYDROXYZINE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OXCARBAZEPINE, ROSUVASTATIN, VALSARTAN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 436 | 25069629 |
US |
29 | 2 |
Completed suicide, Toxicity to various agents, |
||||
TOPIRAMATE, TOPIRAMATE SPINKLE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, CLONAZEPAM, GABAPENTIN, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, |
||||
| 437 | 25069687 |
US |
18 | 1 |
Toxicity to various agents, |
||||
RISPERIDONE, AMLODIPINE, PRAZOSIN, VORTIOXETINE, |
||||
| 438 | 25069703 |
US |
24 | 2 |
Toxicity to various agents, Drug abuse, |
||||
RISPERIDONE, FENTANYL, |
||||
| 439 | 25069742 |
US |
32 | 2 |
Completed suicide, Toxicity to various agents, |
||||
TOPIRAMATE, TOPIRAMATE SPINKLE, BUPROPION HYDROCHLORIDE, BUPROPION, CITALOPRAM, CITALOPRAM HYDROBROMIDE, OXYCODONE, |
||||
| 440 | 25069777 |
US |
45 | 2 |
Toxicity to various agents, |
||||
TOPIRAMATE, TOPIRAMATE SPINKLE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, |
||||
| 441 | 25069788 |
US |
37 | 2 |
Toxicity to various agents, |
||||
HALOPERIDOL, HALOPERIDOL LACTATE, |
||||
| 442 | 25069796 |
US |
75 | 2 |
Medication error, Toxicity to various agents, |
||||
HALOPERIDOL, HALOPERIDOL LACTATE, CLOZAPINE, SERTRALINE, |
||||
| 443 | 25069811 |
US |
33 | 1 |
Toxicity to various agents, |
||||
HALOPERIDOL, HALOPERIDOL LACTATE, PRAZOSIN, BENZTROPINE, SERTRALINE, OLANZAPINE, |
||||
| 444 | 25069847 |
US |
56 | 2 |
Toxicity to various agents, Completed suicide, |
||||
RISPERIDONE, |
||||
| 445 | 25069871 |
US |
40 | 1 |
Toxicity to various agents, Intentional product misuse, |
||||
TOPIRAMATE, TOPIRAMATE SPINKLE, FENTANYL, CITALOPRAM, CITALOPRAM HYDROBROMIDE, OLANZAPINE, |
||||
| 446 | 25070180 |
US |
61 | 1 |
Toxicity to various agents, Off label use, |
||||
BORTEZOMIB, VINCRISTINE SULFATE, DOXORUBICIN, ETOPOSIDE PHOSPHATE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 447 | 25070317 |
CN |
||
Toxicity to various agents, |
||||
ZOLPIDEM TARTRATE, |
||||
| 448 | 25070319 |
PL |
||
Vomiting, Dizziness, Electrolyte imbalance, International normalised ratio increased, Overdose, Toxicity to various agents, Toxicity to various agents, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, SERTRALINE, |
||||
| 449 | 25070369 |
2 | ||
Acute kidney injury, Immune-mediated nephritis, Toxicity to various agents, |
||||
PEMBROLIZUMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 450 | 25074816 |
|||
Incorrect drug administration rate, Toxicity to various agents, |
||||
LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, |
||||
| 451 | 25061631 |
FR |
8 | 1 |
Incorrect dosage administered, Toxicity to various agents, |
||||
RISPERIDONE, RISPERIDONE, |
||||
| 452 | 25062090 |
US |
21 | 1 |
Seizure, Psychotic disorder, Mania, Toxicity to various agents, Drug interaction, Off label use, |
||||
BUPROPION HYDROCHLORIDE, BUPROPION, BUPROPION HYDROCHLORIDE, BUPROPION, ATOMOXETINE, ATOMOXETINE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, ALPRAZOLAM, LORAZEPAM, LORAZEPAM, DIVALPROEX SODIUM, |
||||
| 453 | 25062106 |
US |
38 | 2 |
Brain death, Hypotension, Bradycardia, Bradypnoea, Arrhythmia, Electrocardiogram QT prolonged, Myocardial injury, Myocardial ischaemia, Respiratory depression, Coma, Depressed level of consciousness, Seizure, Metabolic acidosis, Cardiac arrest, Toxicity to various agents, |
||||
BUPROPION HYDROCHLORIDE, BUPROPION, |
||||
| 454 | 25062116 |
US |
29 | 1 |
Toxicity to various agents, |
||||
BUPROPION HYDROCHLORIDE, BUPROPION, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, CLONAZEPAM, HYDROXYCHLOROQUINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 455 | 25062370 |
ES |
45 | 2 |
Disease progression, Toxicity to various agents, Mucosal inflammation, Palmar-plantar erythrodysaesthesia syndrome, |
||||
CAPECITABINE, VINORELBINE, DOXORUBICIN, CARBOPLATIN, CARBOPLATIN, |
||||
| 456 | 25062376 |
JP |
22 | 2 |
Toxicity to various agents, Intentional overdose, |
||||
VONOPRAZAN FUMARATE, |
||||
| 457 | 25062377 |
JP |
31 | 2 |
Toxicity to various agents, Intentional product misuse, |
||||
VONOPRAZAN FUMARATE, |
||||
| 458 | 25062378 |
JP |
22 | 2 |
Toxicity to various agents, Intentional overdose, |
||||
VONOPRAZAN FUMARATE, |
||||
| 459 | 25062659 |
FR |
49 | 1 |
Coma, Toxicity to various agents, |
||||
AMOXICILLIN, BACLOFEN, OXAZEPAM, |
||||
| 460 | 25062701 |
AU |
||
Toxicity to various agents, Incorrect route of product administration, |
||||
LISDEXAMFETAMINE, LISDEXAMFETAMINE, |
||||
| 461 | 25062724 |
AU |
||
Toxicity to various agents, Incorrect route of product administration, |
||||
METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 462 | 25062957 |
JP |
42 | 2 |
Dizziness, Muscular weakness, Toxicity to various agents, Drug interaction, Neutropenia, |
||||
CAPECITABINE, PHENYTOIN, OXALIPLATIN, |
||||
| 463 | 25063025 |
CN |
32 | 2 |
Cardiogenic shock, Toxicity to various agents, Acute kidney injury, Intentional overdose, |
||||
AMLODIPINE, |
||||
| 464 | 25063030 |
PL |
24 | 2 |
Somnolence, Blood pressure decreased, Suicide attempt, Toxicity to various agents, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, AMLODIPINE BESYLATE, |
||||
| 465 | 25063042 |
FR |
26 | 1 |
Drug abuse, Suicidal ideation, Anxiety, Toxicity to various agents, Somnolence, |
||||
ALPRAZOLAM, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, |
||||
| 466 | 25063118 |
CN |
32 | 2 |
Cardiogenic shock, Vasoplegia syndrome, Toxicity to various agents, Intentional overdose, |
||||
AMLODIPINE BESYLATE, |
||||
| 467 | 25063286 |
59 | 1 | |
Nausea, Vomiting, Abdominal pain, Hypophagia, Dizziness postural, Colitis, Proctitis, Hyponatraemia, Hypokalaemia, Neutropenia, Toxicity to various agents, Diarrhoea, Palmar-plantar erythrodysaesthesia syndrome, Mucosal inflammation, Gastrooesophageal reflux disease, Decreased appetite, Asthenia, Erythema, Sensitive skin, Stomatitis, Cheilitis, |
||||
CAPECITABINE, |
||||
| 468 | 25063415 |
FR |
12 | 1 |
Aspergillus infection, Pseudomonas infection, Toxicity to various agents, Drug ineffective, Respiratory tract infection, Renal vein thrombosis, Bronchostenosis, Cystitis haemorrhagic, Drug ineffective for unapproved indication, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, PREDNISONE, EVEROLIMUS, EVEROLIMUS TABLETS, VORICONAZOLE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, HYDROXYCHLOROQUINE, RUXOLITINIB, AMPHOTERICIN B, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ENOXAPARIN SODIUM, RIVAROXABAN, |
||||
| 469 | 25063895 |
JP |
58 | 1 |
Pseudomonas infection, Alpha haemolytic streptococcal infection, Toxicity to various agents, Lymphocyte count decreased, Haemoglobin decreased, Platelet count decreased, Bacteraemia, |
||||
ISATUXIMAB, |
||||
| 470 | 25063968 |
US |
56 | 1 |
Cardiogenic shock, Toxicity to various agents, |
||||
| 471 | 25064074 |
US |
60 | 2 |
BRASH syndrome, Toxicity to various agents, |
||||
DIGOXIN, DIGOXIN, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, APIXABAN, |
||||
| 472 | 25064611 |
CH |
12 | 1 |
Toxicity to various agents, Acute lymphocytic leukaemia recurrent, |
||||
BLINATUMOMAB, INOTUZUMAB OZOGAMICIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 473 | 25064613 |
US |
||
Toxicity to various agents, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 474 | 25064704 |
FR |
16 | 2 |
Toxicity to various agents, Drug interaction, Cognitive disorder, Disorganised speech, Disorientation, Headache, Labelled drug-drug interaction issue, Confusional state, Mydriasis, Hallucinations, mixed, Sinus tachycardia, Wrong technique in product usage process, Substance use, |
||||
SERTRALINE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, HYDROXYZINE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, |
||||
| 475 | 25064915 |
FR |
34 | |
Toxicity to various agents, Hepatic cytolysis, Nephropathy toxic, Liver injury, Coma, Pulmonary oedema, Myocarditis, Bladder injury, Coronary artery disease, Pancreatic injury, Prescribed overdose, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, FENTANYL, DIAZEPAM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 476 | 25064985 |
CN |
||
Toxicity to various agents, Chest discomfort, Palpitations, Chest pain, Abdominal pain, Diarrhoea, Dyspnoea, Nausea, Intentional overdose, |
||||
ZOLPIDEM TARTRATE, LORAZEPAM, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 477 | 25065197 |
IT |
43 | 2 |
Posterior reversible encephalopathy syndrome, Toxicity to various agents, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, TRETINOIN, |
||||
| 478 | 25065299 |
AU |
||
Toxicity to various agents, Circulatory collapse, |
||||
METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 479 | 25067907 |
52 | 1 | |
Electrolyte imbalance, Escherichia infection, Blood pressure increased, Toxicity to various agents, |
||||
MYCOPHENOLIC ACID, MYCOPHENILIC ACID, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, AMLODIPINE BESYLATE, GABAPENTIN, LOSARTAN, NIFEDIPINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PANTOPRAZOLE, |
||||
| 480 | 25056322 |
US |
43 | 1 |
Toxicity to various agents, Infection, |
||||
CAPECITABINE, OXALIPLATIN, |
||||
| 481 | 25056390 |
ZA |
||
Non-cardiogenic pulmonary oedema, Pulmonary embolism, Suicide attempt, Toxicity to various agents, Intentional overdose, Metabolic acidosis, Hypocalcaemia, Nosocomial infection, Sinus tachycardia, Hypotension, |
||||
AMLODIPINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 482 | 25056519 |
AU |
45 | |
Toxicity to various agents, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), METHADONE HYDROCHLORIDE, METHADONE, MORPHINE, PREGABALIN, CANNABIDIOL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 483 | 25056592 |
SE |
||
Intentional self-injury, Intentional overdose, Fatigue, Toxicity to various agents, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 484 | 25057169 |
IT |
19 | 1 |
Completed suicide, Toxicity to various agents, Intentional overdose, |
||||
ALPRAZOLAM, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 485 | 25057226 |
IT |
27 | 1 |
Intentional overdose, Completed suicide, Toxicity to various agents, |
||||
ALPRAZOLAM, OXYCODONE, |
||||
| 486 | 25057812 |
ES |
7 | 1 |
Drug level increased, Toxicity to various agents, Thrombocytopenia, |
||||
LINEZOLID, |
||||
| 487 | 25057823 |
US |
17 | 2 |
Intentional overdose, Toxicity to various agents, Nausea, Vomiting, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, TRANEXAMIC ACID, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, CAFFEINE, |
||||
| 488 | 25057910 |
US |
16 | 1 |
Completed suicide, Pulmonary congestion, Toxicity to various agents, Kidney congestion, Intentional overdose, Cardiac arrest, Cardiac failure acute, Nausea, Vomiting, Dyspnoea, Prescription drug used without a prescription, |
||||
CAFFEINE, NALOXONE, |
||||
| 489 | 25057985 |
US |
70 | 1 |
Blood pressure fluctuation, Toxicity to various agents, Generalised tonic-clonic seizure, Incorrect route of product administration, Wrong product administered, |
||||
TRANEXAMIC ACID, |
||||
| 490 | 25058563 |
US |
79 | 1 |
Tubulointerstitial nephritis, Renal tubular injury, Kidney fibrosis, Toxicity to various agents, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, PREDNISONE, |
||||
| 491 | 25058892 |
US |
9 | 2 |
Toxicity to various agents, Seizure, Drug interaction, |
||||
PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, RANOLAZINE, EXTENDED-RELEASE, RANOLAZINE, EXTENDED-RELEASE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, LOSARTAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DAPAGLIFLOZIN, INSULIN ASPART, INSULIN DEGLUDEC, LEVOTHYROXINE SODIUM, VIBEGRON, DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG, DOCUSATE SODIUM, SENNOSIDES, DOCUSATE SODIUM, 50 MG SENNOSIDES, 8.6 MG, SENNOSIDES AND DOCUSATE SODIUM, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, LINACLOTIDE, FAMOTIDINE, MAGNESIUM OXIDE, ERGOCALCIFEROL, |
||||
| 492 | 25059030 |
NL |
64 | 1 |
Toxicity to various agents, Post-injection delirium sedation syndrome, Electrocardiogram QT prolonged, Hypertension, Muscle rigidity, Overdose, Off label use, Off label use, |
||||
OLANZAPINE PAMOATE, OLANZAPINE PAMOATE, OLANZAPINE PAMOATE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, |
||||
| 493 | 25059897 |
ZA |
2 | |
Suicide attempt, Intentional overdose, Toxicity to various agents, Non-cardiogenic pulmonary oedema, Hypotension, Respiratory distress, Hypocalcaemia, Metabolic acidosis, Sinus tachycardia, Dizziness, |
||||
AMLODIPINE, AMLODIPINE, AMLODIPINE, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 494 | 25059899 |
SE |
43 | 2 |
Hypokalaemia, Suicide attempt, Hyponatraemia, Hypoglycaemia, Toxicity to various agents, Intentional overdose, |
||||
| 495 | 25060483 |
FR |
28 | 2 |
Toxicity to various agents, |
||||
FLUOXETINE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), TRAMADOL HYDROCHLORIDE, PREGABALIN, |
||||
| 496 | 25060501 |
US |
16 | 1 |
Drug interaction, Immunosuppressant drug level increased, Toxicity to various agents, |
||||
NIRMATRELVIR AND RITONAVIR, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 497 | 25060562 |
FR |
28 | 2 |
Toxicity to various agents, |
||||
DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), TRAMADOL HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, PREGABALIN, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, |
||||
| 498 | 25060721 |
CN |
14 | 1 |
Skin burning sensation, Transaminases increased, Tachypnoea, Hypertonia, Urine output decreased, Toxicity to various agents, |
||||
METHOTREXATE SODIUM, |
||||
| 499 | 25054727 |
ES |
40 | 2 |
Toxicity to various agents, |
||||
ADALIMUMAB, ADALIMUMAB, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, DULOXETINE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, MESALAMINE, MIRTAZAPINE, CLORAZEPATE DIPOTASSIUM, |
||||
| 500 | 25054837 |
US |
58 | 2 |
Acute myocardial infarction, Acute respiratory failure, Autoimmune hepatitis, Chronic hepatic failure, Transaminases increased, Anaemia, Abdominal pain, Asthenia, Jaundice, Toxicity to various agents, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28